The aetiology of cervical neoplasia has been studied epidemiologically for over 150 years. More recently, experimental approaches have been applied and, with the advent of molecular biology, putative infectious agents can now be studied more easily and with greater precision. There is now considerable evidence that the risk of developing cervical cancer is, in part, sexually transmitted.'2 The most likely explanation for this is that an infectious agent is involved but much of the interpretation of epidemiological studies has, of necessity, been performed without knowledge of the identity of this agent. With increasing evidence, both epidemiological and experimental, that human papillomavirus (HPV) is the infectious agent in question, the role of other factors can now be addressed with more confidence. In the first part of this review the molecular evidence implicating HPV in cervical neoplasia will be considered; in the second the evidence for the involvement of other factors will be reviewed and the potential role of HPV testing in clinical practice addressed.
Introduction
The aetiology of cervical neoplasia has been studied epidemiologically for over 150 years. More recently, experimental approaches have been applied and, with the advent of molecular biology, putative infectious agents can now be studied more easily and with greater precision. There is now considerable evidence that the risk of developing cervical cancer is, in part, sexually transmitted.'2 The most likely explanation for this is that an infectious agent is involved but much of the interpretation of epidemiological studies has, of necessity, been performed without knowledge of the identity of this agent. With increasing evidence, both epidemiological and experimental, that human papillomavirus (HPV) is the infectious agent in question, the role of other factors can now be addressed with more confidence. In the first part of this review the molecular evidence implicating HPV in cervical neoplasia will be considered; in the second the evidence for the involvement of other factors will be reviewed and the potential role of HPV testing in clinical practice addressed.
Molecular organisation and classification of human papillomaviruses Papillomaviruses are non-enveloped, double stranded DNA viruses about 55 nm in diameter and with a circular genome approximately 8 kilobases in length. Traditionally, they have been included in the papovaviridae and this remains the recommendation of the International Committee on Taxonomy of Viruses.' However, they are sufficiently dissimilar from the other members of the group, both in terms of virion size and genomic organisation, to be regarded as a separate group. 3 .' Analysis of viral messenger RNA (mRNA) production using in situ hybridisation has shown that E gene expression is found throughout the epithelium, but L gene expression is only seen in terminally differentiated keratinocytes, where it is accompanied by capsid protein production."' This form of infection leads to the cytopathic effect of HPV in squamous epithelial cells, with koilocytosis, nuclear enlargement, dyskeratosis, and multinucleation being the major changes. Non-permissive transformable infection describes the situation in which viral replication and vegetative viral production do not occur, but viral DNA persists within the cell either as an extra-chromosomal element or by integration into the host genome. This persistence may be associated with cellular transformation as in high grade cervical intraepithelial neoplasia (CIN) and invasive squamous cell carcinoma (ISCC) (see Part II). HPV infection of columnar glandular epithelia is being increasingly described,'7 and may also represent this form of infection.
From a clinical point of view, three forms of infection can be defined: latent HPV infection in which HPV DNA is detectable by molecular means but without accompanying clinical, cytological, or histological abnormality; subclinical HPV infection which is not detectable by naked eye examination-that is, it requires colposcopy, or microscopy for identification; and clinical HPV infection which is visible to the unaided eye. 14 The HPV types found in subclinical and clinical anogenital infections are associated more with the histopathology than the site of the lesion. Thus, a condyloma acuminatum is likely to be infected with HPV 6 35 and show that the prevalence of HPV is age dependent, being consistently only 1-2% over the age of 35 years.36 Clearly, the figures obtained partly depend on the population studied but there does appear to be a difference between patients with normal and dyskaryotic smears. A recent PCR based case-control study suggests that most grades of CIN can be attributed to HPV infection. 37 The use of semiquantitative PCR techniques has revealed a correlation between higher amounts of "intermediate" and "high risk" HPV DNA and CIN II or III, a finding which is consistent with results obtained using in situ hybridisation.3942 This may simply represent the molecular equivalent of distinguishing between latent and subclinical/clinical HPV infection by these types, an interpretation which is supported by the observation that, in all cases in which apparently normal cervical smears were positive on in situ hybridisation, the morphology of the positive cells appeared abnormal.26 Nevertheless, this distinction may be of clinical relevance (see Part II).
Molecular pathology of cervical lesions and cell lines There are four main events in the interaction between HPVs and the host cell: infection, integration, transcription, and translation. Most data are available for squamous lesions, which will be considered first.
SQUAMOUS CERVICAL LESIONS
HPV sequences have been localised to squamous epithelial cell nuclei by in situ hybridisation. 43 Invasive cervical carcinoma and CIN III lesions often contain areas of lower grade CIN adjacent to the main lesion. Analysis of this situation by in situ hybridisation has shown that the same HPV type is present in areas of all grades of CIN including the main lesion, suggesting that these areas represent sequential steps in the same process.44 This observation also suggests that HPV infection occurs early in the process of cervical carcino-genesis. "Intermediate" and "high risk" HPV types are associated more with CIN II and III than with HPV infection alone or CIN I both on in situ hybridisation" and PCR,45 an observation which is consistent with the epidemiological data. ISCCs consistently contain HPV sequences, particularly "high risk" types, with most studies reporting over 85% of tumours positive and some series 100% positivity on PCR. 35 The HPV genome is integrated in all HPV containing cell lines studied to date either arising spontaneously46 or induced in vitro.47 Viral integration is also associated with CIN III and ISCC, being demonstrable by both conventional molecular techniques and in situ hybridisation ( fig 5) .27 29 However, integrated sequences often co-exist with episomal sequences within the same lesion27 29 48 and not all invasive carcinomas contain integrated sequences. Viral integration into the host genome appears to occur at random at fragile sites4647 but the site of breakage of the viral genome is more consistent, occurring in the E1/E2 region. The E2 gene is involved in the control of viral transcription,8 suggesting that a break at this point may lead to enhanced transforming gene transcription. The finding that mutation of the E1/E2 genes of HPV 16 enhances viral immortalising capacity49 is consistent with this possibility in view of the role of the E2 gene in the repression of E6 and E7 gene expression. 5 The The approach to the study of cultured normal cells involves the use of the cooperation assay which has defined two categories of oncogenes: establishment genes and transforming genes.59 In general, one or more genes from each of these groups are required for cellular transformation, and both human fibroblasts and keratinocytes can be immortalised, but not transformed, by HPV 16 DNA. Transformation, therefore, requires other genes and is discussed in Part II. RAFT 
CULTURES
In vitro collagen raft culture systems, where keratinocytes are permitted to differentiate morphologically, enable the effect of HPV DNA on "epithelial" morphology to be studied.60 HPV 16 DNA induced morphological changes in foreskin keratinocytes were indistinguishable from CIN in this system and were associated with viral integration, aneuploidy, and chromosome aberrations.60 E6/E7 mRNA was also present in the abnormal cells. However, morphological CIN was produced after only a few hundred generations and therefore this model does not accurately reflect the time-course of cervical neoplasia, suggesting that viral integration may be accelerated in this system. Fetal ectocervical cells transfected with HPV 16 showed abnormal patterns of differentiation similar to CIN in a similar system6' and the culture of cell lines containing episomal viral sequences has now been achieved. 62 These studies show that HPV sequences can induce lesions with the morphology of CIN and that productive viral infections can be cultivated in vitro. Therefore, these systems will be of importance in the analysis both of productive viral infection itself and of events involved in the genesis and progression of CIN.
TRANSGENIC MICE Transgenic mice have been used to examine the effects of the E6/E7 genes of HPV 16 in vivo. When coupled to a fl-actin promoter, these genes led to the formation of neuroepithelial tumours in the transgenic clones. 63 However, E6/E7 RNA was only expressed in the tumours and not in surrounding tissues, suggesting a localised effect. Linkage of the E6/E7 genes to the a-crystallin promoter led to microphthalmia and cataracts, and the formation of lens tumours in a large proportion of transgenic animals, showing that localised gene expression can lead to tumour development at that site. 64 These studies provide evidence that the E6/E7 genes of HPV 16 have transforming function in vivo as well as in vitro and further study of transgenic models will allow analysis of the other factors involved in tumour progression.
Conclusions
There is clear evidence that different HPV types are associated with different lesions allowing the distinction of "high", "intermediate", and "low risk" HPV types. Molecular epidemiological and pathological studies confirm this stratification and support a role for HPV in the process of cervical carcinogenesis. However, HPV infection often regresses and, where it is associated with neoplasia, is an early event. Therefore, other factors must be involved and these are discussed in Part II.
